What is trans-resveratrol?

Trans-resveratrol is the biologically active isomer of resveratrol, a polyphenol found in grape skin, red wine, peanuts and berries. Most of the mechanistic research on sirtuin activation, endothelial nitric oxide and vascular health has focused on the trans form. Commercial supplements vary widely: some list total resveratrol or "red wine extract", while others specify the trans-resveratrol content. For readers comparing products, our resveratrol buyer's guide explains the difference.

The heart-health mechanism

Several pathways have been proposed, mainly from cell and animal studies:

  • Endothelial function: Resveratrol may increase nitric oxide bioavailability and improve flow-mediated dilation, a marker of blood-vessel health.
  • Oxidative stress: It has antioxidant properties in vitro and may reduce oxidised LDL formation in animal models.
  • Inflammation: Cell studies suggest it can lower NF-κB activity and inflammatory cytokines linked to atherosclerosis.
  • Platelet aggregation: Preclinical work shows antiplatelet effects, which is also the source of its interaction risk with blood thinners.

These mechanisms are promising, but they do not automatically translate into clinically meaningful heart benefits in humans.

What do human trials show?

Human evidence is mixed and generally short-term. A 2022 meta-analysis of randomised controlled trials found that resveratrol supplementation was associated with small reductions in systolic blood pressure in people with metabolic syndrome or overweight, but the effect was not consistent across all populations. Other trials have reported minor improvements in endothelial function markers, while larger or longer studies have found no significant effect on cardiovascular outcomes.

Key caveats:

  • Study doses range from 150mg to 1000mg per day, often with different formulations and co-factors such as piperine or quercetin.
  • Many trials are small, short (8–12 weeks), and conducted in specific groups such as people with type 2 diabetes or obesity.
  • No large, long-term trial has shown that resveratrol reduces heart attacks, strokes or cardiovascular mortality.

For a broader look at resveratrol and ageing, see our resveratrol, sirtuins and longevity review.

UK practical considerations

Trans-resveratrol is sold as a food supplement in the UK and is not licensed as a medicine. This means it has not been through the MHRA's efficacy and safety assessment for treating heart disease. It should not replace prescribed statins, antihypertensives, anticoagulants or lifestyle measures such as diet, exercise and smoking cessation.

If a UK reader is considering trans-resveratrol for general cardiovascular support, the safest approach is:

  • Choose a product that clearly states the trans-resveratrol dose per serving, not just total resveratrol or extract.
  • Start with the dose on the label and monitor for side effects such as digestive upset or headache.
  • Speak to a GP or pharmacist before use if taking blood pressure medication, blood thinners, or if surgery is planned.

Product note: ProHealth Trans-Resveratrol 1000mg

One UK-available option we have reviewed is the ProHealth Trans-Resveratrol 1000mg. It provides 1000mg trans-resveratrol per two-capsule serving, plus quercetin, red wine extract, green tea extract and BioPerine. At the time of writing it is available on Amazon UK for £29.99, or £26.99 with Subscribe & Save. We disclose affiliate links where used and do not accept payment for rankings.

Bottom line

Trans-resveratrol has plausible cardiovascular mechanisms and some human trials show small improvements in blood pressure and endothelial markers. The evidence is not strong enough to recommend it as a heart treatment, but it may be a reasonable supplement for UK adults interested in general vascular support, provided it is used alongside — not instead of — medical care.